Results 161 to 170 of about 103,228 (328)

Exploring the roles of conserved context‐dependent cis‐regulatory elements (cdCREs) in multicellularity, human health and disease

The FEBS Journal, EarlyView.
Conserved context‐dependent cis‐regulatory elements act as a major reservoir of disease‐associated polymorphisms in the human genome and are also affected by epigenetic change. This ‘state‐of‐the‐art’ review explores the latest developments in studying these enigmatic elements and how the effects of disease‐associated polymorphisms and environmentally ...
Andrew McEwan, Alexander Rattray, Greg Hutchings, Elizabeth Hay, Chris Murgatroyd, Alasdair MacKenzie   +5 more
wiley   +1 more source

Effects of neuropeptide Y and agonists selective for neuropeptide Y receptor sub‐types on arterioles of the guinea‐pig small intestine and the rat brain [PDF]

, 1992
Jun Xia, T O Neild, Neela Kotecha
openalex   +1 more source

Can serum neuropeptide levels help diagnose pediatric migraine? A prospective case–control study

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective The objective of this study was to examine the serum levels of vasoactive neuropeptides (calcitonin gene‐related peptide [CGRP], pituitary adenylate cyclase‐activating peptide‐38 [PACAP‐38], substance P [SP], and vasoactive intestinal peptide [VIP], which have been linked to the pathophysiology of migraine in adults) in pediatric ...
Sibğatullah Ali Orak, Muzaffer Polat, Mert Pak, Çisil Çerçi Kubur, Aslı Kübra Atasever, Celil Yilmaz, Fatma Taneli, Ahmet Angin, Beyhan Cengiz Özyurt   +8 more
wiley   +1 more source

Presynaptic action of neuropeptide Y in area CA1 of the rat hippocampal slice.

, 1987
William F. Colmers, Ken Lukowiak, Quentin J. Pittman   +2 more
openalex   +2 more sources

Functional effects and ligand binding of chimeric galanin‐neuropeptide Y (NPY) peptides on NPY and galanin receptor types [PDF]

, 1994
Ulrika Kahl, Ülo Langel, Tamás Bartfai, Lars Grundemar   +3 more
openalex   +1 more source

Galcanezumab reduces trigeminal nociception and is effective in preclinical models of migraine and trigeminal autonomic cephalalgias

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives/Background This study was undertaken to assess the therapeutic efficacy of galcanezumab in preclinical models of migraine and cluster headache and to determine potential shared trigeminovascular mechanisms of action. Galcanezumab is a humanized monoclonal antibody that binds to the neuropeptide calcitonin gene‐related peptide ...
Marta Vila‐Pueyo, Peter J. Goadsby, Kirk W. Johnson, Philip R. Holland   +3 more
wiley   +1 more source

Binding of Monoiodinated Neuropeptide Y to Hippocampal Membranes and Human Neuroblastoma Cell Lines

, 1989
Søren P. Sheikh, M.M.T. O’Hare, O. Tortora, Thue W. Schwartz   +3 more
openalex   +1 more source

Presynaptic inhibition by neuropeptide Y in rat hippocampal slice in vitro is mediated by a Y₂ receptor [PDF]

, 1991
William F. Colmers, Gloria J. Klapstein, Alain Fournier, Serge St‐Pierre, Kerri A. Treherne   +4 more
openalex   +1 more source

Feeding inhibition by neuropeptide Y [PDF]

Nature, 1996
L. Arthur Campfield, Françoise J. Smith, John Moschera, Pascal Bailon, Paul Burn   +4 more
openaire   +3 more sources

Functional sympatholysis of neuropeptide Y-mediated vasoconstriction in humans. [PDF]

J Physiol
Wakeham DJ, Hissen SL, MacNamara JP, Davis SL, Fadel PJ, Levine BD, Hearon CM.   +6 more
europepmc   +1 more source